Helius Medical Technologies Inc
Change company Symbol lookup
Select an option...
HSDT Helius Medical Technologies Inc
ICPT Intercept Pharmaceuticals Inc
BMY Bristol-Myers Squibb Co
DTCFF Defence Therapeutics Inc
STKH Steakholder Foods Ltd
ADBE Adobe Inc
FATP Fat Projects Acquisition Corp
LGVC LAMF Global Ventures I Corp
SECO Secoo Holding Ltd
SGBXV Safe & Green Holdings Corp
Go

Health Care : Health Care Equipment & Supplies | Small Cap Value
Company profile

Helius Medical Technologies, Inc. is a neurotech company focused on neurological wellness. The Company focuses on developing, licensing or acquiring non-implanted technologies targeted at reducing symptoms of neurological disease or trauma. The Company's product, Portable Neuromodulation Stimulator (PoNS), is a non-implanted medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS is used as a short-term treatment of gait deficit due to mild-to-moderate symptoms for multiple sclerosis (MS) and is to be used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only. It is also used as a short-term treatment (14 weeks) of chronic balance deficit due to mild-to-moderate traumatic brain injury (mmTBI) and is to be used in conjunction with physical therapy (PoNS Therapy).

Price
Delayed
$7.87
Day's Change
0.2014 (2.63%)
Bid
--
Ask
--
B/A Size
--
Day's High
8.03
Day's Low
7.64
Volume
(Heavy Day)

Today's volume of 29,426 shares is on pace to be much greater than HSDT's 10-day average volume of 69,857 shares.

29,426

Unable to locate that news article. Back to news results

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.